GlassScriptPhysician profile
Warren W Scott
NPI 1053364877
$1,455.67
in general payments reported to CMS, 2019-2025
14 companies · $17.00 in 2025
The $17.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $129 · 2021: $470 · 2022: $538 · 2023: $110 · 2024: $15.83 · 2025: $17.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.08 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Organon LLC | $169.27 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $97.31 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $80.91 | 2021-2022 | |
| Lupin INC. | $75.90 | 2019-2021 | |
| Evofem Biosciences, INC. | $62.69 | 2021-2023 | Phexxi |
| Agile Therapeutics, INC. | $57.81 | 2021-2022 | |
| Myovant Sciences INC. | $54.40 | 2022 | |
| Scynexis, INC. | $51.81 | 2022 | |
| Merck Sharp & Dohme LLC | $45.15 | 2019-2020 | |
| Exeltis, USA INC. | $31.58 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.93 | 2019 | |
| Biomerieux INC | $17.00 | 2025 | |
| Coopersurgical, INC. | $15.83 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.